ArticleScience advances2023
Remote epitaxial interaction through graphene.
Article in Science advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Charge-mediated remote epitaxy of GaScience advances · 2026Article
- Article
- Low Temperature Growth of High-Quality Wurtzite Ferroelectric Through Quasi-van der Waals Epitaxy.Advanced materials (Deerfield Beach, Fla.) · 2026Article
- Van der Waals template-encoded soft epitaxy of tellurium enabled by atomic layer deposition.Science advances · 2026Article
- Article
- Substrate-field-modulated remote-van der Waals hybrid epitaxy in transition metal dichalcogenide heterostructures.Nano convergence · 2026Article
- Emergent Freestanding Complex Oxide Membranes for Multifunctional Applications.Advanced materials (Deerfield Beach, Fla.) · 2026Review
- Van der Waals Template-Assisted Growth of Two-dimensional SbAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
- A universal 2D-on-SiC platform for heterogeneous integration of epitaxial III-N membranes.Science advances · 2025Article
- Overcoming Material Incompatibility via 2D Free-Surface Engineering.Advanced materials (Deerfield Beach, Fla.) · 2025Article
- Epitaxy of Emerging Materials and Advanced Heterostructures for Microelectronics and Quantum Sciences.Small methods · 2025Article
- Van der Waals Epitaxy of 2D Gallium Telluride on Graphene: Growth Dynamics and Principal Component Analysis.Small (Weinheim an der Bergstrasse, Germany) · 2025Article
- Constructing Two-Dimensional, Ordered Networks of Carbon-Carbon Bonds with Precision.Precision chemistry · 2025Review
- Remote epitaxy and exfoliation of vanadium dioxide via sub-nanometer thick amorphous interlayer.Nature communications · 2025Article
- From oxide epitaxy to freestanding membranes: Opportunities and challenges.Science advances · 2024Review
- Advancements and Challenges in the Integration of Indium Arsenide and Van der Waals Heterostructures.Small (Weinheim an der Bergstrasse, Germany) · 2024Review
- Influence of Synthesis Parameters on Structure and Characteristics of the Graphene Grown Using PECVD on Sapphire Substrate.Nanomaterials (Basel, Switzerland) · 2024Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The concept of remote epitaxy involves a two-dimensional van der Waals layer covering the substrate surface, which still enable adatoms to follow the atomic motif of the underlying substrate. The mode of growth must be carefully defined as defects, e.g., pinholes, in two-dimensional materials can allow direct epitaxy from the substrate, which, in combination with lateral epitaxial overgrowth, could also form an epilayer. Here, we show several unique cases that can only be observed for remote epitaxy, distinguishable from other two-dimensional material-based epitaxy mechanisms. We first grow BaTiO
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.